1. Todd JA. Human genetics. Tackling common disease. Nature. 2001; 411:537Y539.
2. Russel MG, Pastoor CJ, Janssen KM, et al. Familial aggregation of inflammatory bowel disease: a population-based study in South Limburg, the Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol. 1997; 223(suppl 32):S88–S91.
3. Park JB, Yang SK, Byeon JS, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006; 12:1146–1151.
Article
4. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549.
Article
5. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002; 15:79–94.
Article
6. Cho JH. Update on the genetics of inflammatory bowel-disease. Curr Gastroenterol Rep. 2001; 3:458–463.
7. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126:1504–1517.
Article
8. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001; 7:260–270.
Article
9. Orholm M, Munkholm P, Langholz E, Nielsen OH, S⊘ rensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991; 324:84–88.
Article
10. Van Limbergen J, Russell RK, Nimmo ER, et al. Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13:338–355.
Article
11. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002; 123:86–91.
Article
12. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003; 17:1465–1470.
Article
13. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003; 11:6–16.
Article
14. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000; 68:7010–7017.
Article
15. Lee KM, Chung WC, Paik CN, et al. A polymorphism of CD14 is associated with inflammatory bowel disease in Korean population. Gastroenterology. 2009; 136(suppl 1):A–368.
16. Yang SK, Park M, Lim J, et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis. 2009; 15:1385–1390.
Article
17. Cho HS, Byun TJ, Ahn SB, et al. A case of familial Crohn's disease observed in a parent and his offspring. Korean J Gastroenterol. 2008; 52:247–250.
18. Hubacek JA, Rothe G, Pit'ha J, et al. C(-260)→ T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999; 99:3218–3220.